Standout Papers

Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastase... 2013 2026 2017 2021 825
  1. Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial (2013)
    Bernard Nordlinger, Halfdan Sørbye et al. The Lancet Oncology

Immediate Impact

2 from Science/Nature 50 standout
Sub-graph 1 of 23

Citing Papers

Colorectal cancer
2024 Standout
Augmenting Cancer Therapy with a Supramolecular Immunogenic Cell Death Inducer: A Lysosome-Targeted NIR-Light-Activated Ruthenium(II) Metallacycle
2024 Standout
1 intermediate paper

Works of E. Tanis being referenced

Prognostic impact of immune response in resectable colorectal liver metastases treated by surgery alone or surgery with perioperative FOLFOX in the randomised EORTC study 40983
2015
Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial
2013 Standout

Author Peers

Author Last Decade Papers Cites
E. Tanis 871 410 159 716 12 1.2k
Cyril Hatem 807 353 168 639 5 1.2k
Olivier Coatmeur 654 317 163 587 4 1.0k
Cees Verhoef 553 450 185 439 15 1.2k
R. Adam 877 600 121 766 25 1.6k
Richard Stang 854 572 106 988 7 1.2k
Martin Paul 856 603 106 988 7 1.3k
Marc Pocard 730 585 77 791 23 1.1k
Barbara J. Maclean 1001 533 62 585 13 1.4k
Adrian Valeanu 885 468 114 864 5 1.1k
William Alago 540 370 237 809 26 1.3k

All Works

Loading papers...

Rankless by CCL
2026